Freestone Capital Holdings’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-47,347
| Closed | -$1.5M | – | 461 |
|
|
2022
Q1 | $1.5M | Sell |
47,347
-286
| -0.6% | -$9.05K | 0.06% | 213 |
|
|
2021
Q4 | $1.06M | Buy |
+47,633
| New | +$1.06M | 0.04% | 229 |
|
|
2021
Q1 | – | Sell |
-25,000
| Closed | -$663K | – | 511 |
|
|
2020
Q4 | $663K | Buy |
25,000
+15,000
| +150% | +$398K | 0.04% | 223 |
|
|
2020
Q3 | $153K | Hold |
10,000
| – | – | 0.01% | 359 |
|
|
2020
Q2 | $203 | Hold |
10,000
| – | – | ﹤0.01% | 327 |
|
|
2020
Q1 | $103 | Buy |
+10,000
| New | +$103 | ﹤0.01% | 359 |
|
|
2016
Q1 | – | Sell |
-2,903
| Closed | -$316K | – | 333 |
|
|
2015
Q4 | $316K | Sell |
2,903
-946
| -25% | -$103K | 0.03% | 294 |
|
|
2015
Q3 | $384K | Buy |
3,849
+516
| +15% | +$51.5K | 0.04% | 262 |
|
|
2015
Q2 | $380K | Buy |
3,333
+124
| +4% | +$14.1K | 0.06% | 184 |
|
|
2015
Q1 | $335K | Buy |
3,209
+955
| +42% | +$99.7K | 0.05% | 149 |
|
|
2014
Q4 | $271K | Sell |
2,254
-633
| -22% | -$76.1K | 0.04% | 152 |
|
|
2014
Q3 | $423K | Buy |
2,887
+186
| +7% | +$27.3K | 0.07% | 116 |
|
|
2014
Q2 | $451K | Buy |
2,701
+239
| +10% | +$39.9K | 0.07% | 143 |
|
|
2014
Q1 | $489K | Buy |
2,462
+983
| +66% | +$195K | 0.09% | 124 |
|
|
2013
Q4 | $282K | Buy |
1,479
+88
| +6% | +$16.8K | 0.05% | 228 |
|
|
2013
Q3 | $236K | Buy |
+1,391
| New | +$236K | 0.04% | 289 |
|